Medical Research

EXPERIENCE

Fresenius, Bad-homburg, Germany

April 13th, 2015 - Present

Medical Science Liaison,

Contract-Healthstar

. Interact with Medical Directors and clinical staff through North-

East/ New England Territory.

. Cross collaboration with clinical support specialists

. Provide accurate and timely information to Medical Directors regarding

Erythropoetin stimulating agents

Bristol-Myers Squibb, Plainsboro, NJ

April 2014 - March 31st, 2015

Clinical Health Educator, Medical Affairs

Contract-The Medical Affairs Company

. Collaborated across matrices of BMS and Pfizer Medical Affairs and

Commercial divisions.

. Supported launch of Eliquis (Apixaban) throughout northern NJ and

Staten Island, NY.

. Brought Eliquis to formulary at new accounts as part of 6-month

collaborative effort.

. Business planning and market strategy with sales force; relationship

building with KOL's.

. Peer to Peer presentations and discussions of on-label data for

Eliquis.

. Accurately responded to queries with evidence based practices and on-

label information.

. Monthly journal club.

Advanced Heart Failure/ VAD program, Morristown, NJ

July 2012 - Present

Co-Investigator, Clinical & Health Outcomes Research

Principle Investigators: Marc Goldschmidt MD, & Mark Zucker MD

. Designed and oversaw outcomes research of inotrope dependent stage-

D/NYHA 4 patients.

. Coordinated team of several opinion leaders across two regional

medical centers.

. Presented findings at regional and national specialty conferences.

. Developed multicenter status.

. Expanding study to include AICD data.

. Expanding study in collaboration with national infusion company.

Morristown Medical Center, Morristown, NJ

July 2012- February, 2015

Intern, Medicine Dept.

. Direct patient care within a number of specialties including

Cardiology, Endocrinology, Pulmonology, Critical Care, Nephrology,

Transplant, Infectious Diseases, Oncology, General Medicine and

Womens' Health.

. Scholarly activity project developed with Advanced Heart Failure

program, continues to advance (see above).

University of Haifa, Haifa, Israel

July 2011 -

May 2012

Post-Doctoral Research Fellow, Cell Death and Cancer Research Laboratory

Principle Investigator: Sarit Larisch, PhD.

. Expanded and successfully published Parkinson's Disease (PD)

translational research.

. Findings supported earlier data suggesting ARTS and Parkin as a

targets for novel therapies for PD.

. Developed stable cell lines of subcloned ARTS-KD in SH-SY5Y, Cos-7 and

H9C2 cell line.

. Optimized protocols for RNAi-electroporation as well as SHRNA.

Rambam Medical Center

January 2009 - May

2011

Technion-Israel Institute of Technology, Haifa, Israel

Research Associate: Dept of Anesthesia

Principle Investigators: Ruth Edry MD & Dror Aizenbud DMD, MS.

. Collaborated with Medasense Corporation, validating sedation

monitoring technology.

. Demonstrated children with congenital intellectual developmental

disorders express lower levels of entropy in sedated states.

. Awarded "Excellence in research".

GlaxoSmithKline, Collegeville, PA

May 2006 - Oct

2006

Assistant Scientist, Discovery Research-Screening Sciences

Contract- Medfocus LLC

. In-vivo drug screening using HepG2 cell line, in vitro Pregnane X

Receptor Assay. and Steadylite High Sensitivity Luminescence Reporter

Gene Assay System.

. In vitro drug screening through use of Titertek Multidrop, Thermo-CRS,

BioCube, ViewLux and Acquest Plate readers.

. Analyzed data with Spotfire, QMole, and Sargen software.

PROFESSIONAL CONSULTING / FEE FOR SERVICE

Telesofia, New York, NY

April 2014

Consultant Medical Editor

Acupera, San Francisco, CA

August 2014

Consultant Clinical Author

EDUCATION

Technion, Ruth and Bruce Rappaport Faculty of Medicine

July 2011

Haifa, Israel

Doctor of Medicine (MD)

Drexel University

June 2005

Philadelphia, PA

Bachelor of Science, Biology (BS)

Minor Judaic Studies

HONORS AND AWARDS

P.R.I.D.E. award

2013

President's Post-Doctoral Research Fellowship

2011-2012

MD Thesis Research Excellence Award

2011

A.J. Drexel Scholarship

2001-2005

Dean's List

2005

Julius and Josephine Cohen Award in Judaic Studies

2005

Spirit of Achievement Award

2002

St Luke's Hospital recognition for volunteering over 400 hours

2000

PUBLICATIONS

Ahmed Harhash, Marshall Rovner, Audrey Kleet, Jacqueline Fearon Clarke,

Kathleen Hollasch, David Baran, Mark Zucker, Marc Goldschmidt: Revisiting

Intravenous Inotropes: Are They as Bad as We Thought in REMATCH. Annual

meeting American College of Cardiology, 2015 (updated and expanded subgroup

data).

*manuscript in process

Marshall Rovner, Ahmed Harhash, Audrey Kleet, Jacqueline Fearon Clarke,

Kathleen Hollasch, David Baran, Mark Zucker, Marc Goldschmidt: Revisiting

Intravenous Inotropes: Are They as Bad as We Thought in REMATCH. Annual

meeting of the Heart Failure Society of America, 2014

Ahmed Harhash, Marshall B. Rovner, Audrey Kleet, Rami Bustami, Michael

Serra, Gian Carlo Giove, Marc Goldschmidt: Continuous infusion of inotropes

in stage-D heart failure (CIHF). Data from the Heart Success program.

Abstract# 18; Mt Sinai Resident and Fellow Research Day, 2014.

Kemeny S, Dery D, Loboda Y, Rovner M, Lev T, et al. (2012) Parkin Promotes

Degradation of the Mitochondrial Pro-Apoptotic ARTS Protein. PLoS ONE 7(7):

e38837. doi:10.1371/journal.pone.0038837.

Edry R, Rovner M, Aizenbud D. (2011) A comparison of entropy values of

mentally retarded and normal children undergoing deep intravenous sedation

for dental treatment. Alpha Omegan. 2011 Fall-Winter; 104(3-4):79-84.

Contact this candidate